Grand Pharmaceutical Group Limited (HKG: 0512)
Hong Kong
· Delayed Price · Currency is HKD
4.310
-0.130 (-2.93%)
Sep 9, 2024, 2:24 PM HKT
Grand Pharmaceutical Group Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | - | 1,880 | 2,079 | 2,403 | 1,793 | 1,151 | Upgrade
|
Depreciation & Amortization | - | 392.21 | 394.91 | 339.52 | 287.06 | 477.14 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 13.06 | 0.18 | 1.55 | -4.99 | 3.2 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 50.14 | 26.36 | 1.51 | -38.64 | 0.47 | Upgrade
|
Loss (Gain) From Sale of Investments | - | -89.27 | 94.62 | -483.68 | -264.97 | 11.67 | Upgrade
|
Loss (Gain) on Equity Investments | - | 25.01 | 43.79 | -113.86 | -61.98 | -114.96 | Upgrade
|
Provision & Write-off of Bad Debts | - | 57.7 | -22.64 | 11.77 | 9.89 | 54.15 | Upgrade
|
Other Operating Activities | - | 219.23 | 119.75 | 144.97 | -36.3 | 70.93 | Upgrade
|
Change in Accounts Receivable | - | -177.52 | -514.24 | -701.65 | -122.23 | -143.55 | Upgrade
|
Change in Inventory | - | -99.41 | -295.28 | -118.74 | -100.96 | -65.12 | Upgrade
|
Change in Accounts Payable | - | 290.65 | -234.58 | 605.5 | 2.49 | -297.15 | Upgrade
|
Change in Unearned Revenue | - | -110.66 | 154.96 | -64.09 | -36.96 | 176.6 | Upgrade
|
Change in Other Net Operating Assets | - | -26.24 | -3.78 | -19.67 | 30.06 | -20.36 | Upgrade
|
Operating Cash Flow | - | 2,425 | 1,843 | 2,006 | 1,456 | 1,304 | Upgrade
|
Operating Cash Flow Growth | - | 31.60% | -8.13% | 37.76% | 11.66% | -7.41% | Upgrade
|
Capital Expenditures | - | -487.73 | -626.22 | -471.57 | -209.01 | -566.04 | Upgrade
|
Sale of Property, Plant & Equipment | - | 6.61 | 1.99 | 23.79 | 1.53 | - | Upgrade
|
Cash Acquisitions | - | -176.42 | -269.22 | -245.41 | - | -20.62 | Upgrade
|
Sale (Purchase) of Intangibles | - | -0.31 | -431.37 | -64.8 | -49.56 | -1.15 | Upgrade
|
Investment in Securities | - | -5.17 | -639.34 | -1,200 | -1,415 | 188.83 | Upgrade
|
Other Investing Activities | - | 147.27 | -395.95 | 142.42 | 319.29 | -44.6 | Upgrade
|
Investing Cash Flow | - | -515.75 | -2,360 | -1,769 | -1,513 | -443.58 | Upgrade
|
Long-Term Debt Issued | - | 2,370 | 3,117 | 1,981 | 2,142 | 1,632 | Upgrade
|
Long-Term Debt Repaid | - | -3,451 | -2,210 | -1,621 | -1,926 | -1,936 | Upgrade
|
Net Debt Issued (Repaid) | - | -1,081 | 906.49 | 359.6 | 215.62 | -304.72 | Upgrade
|
Issuance of Common Stock | - | - | - | - | 1,014 | 102.62 | Upgrade
|
Repurchase of Common Stock | - | -81.01 | -43.99 | -143.5 | - | - | Upgrade
|
Common Dividends Paid | - | -496.94 | -390.45 | -390.45 | -324.25 | -290.47 | Upgrade
|
Other Financing Activities | - | -230.08 | -145.05 | -158.82 | -130.77 | -217.63 | Upgrade
|
Financing Cash Flow | - | -1,889 | 327 | -333.17 | 774.27 | -710.2 | Upgrade
|
Foreign Exchange Rate Adjustments | - | -124.06 | -118.42 | 12.64 | 60.37 | -3.14 | Upgrade
|
Net Cash Flow | - | -104.31 | -308.85 | -83.84 | 777.43 | 147.03 | Upgrade
|
Free Cash Flow | - | 1,937 | 1,216 | 1,534 | 1,247 | 737.91 | Upgrade
|
Free Cash Flow Growth | - | 59.25% | -20.71% | 23.03% | 68.98% | -28.74% | Upgrade
|
Free Cash Flow Margin | - | 18.40% | 12.72% | 17.84% | 19.63% | 11.20% | Upgrade
|
Free Cash Flow Per Share | - | 0.55 | 0.34 | 0.43 | 0.36 | 0.22 | Upgrade
|
Cash Interest Paid | - | 204.36 | 137.49 | 92.96 | 115.42 | 128.61 | Upgrade
|
Cash Income Tax Paid | - | 471.08 | 349.26 | 277.32 | 259.91 | 137.7 | Upgrade
|
Levered Free Cash Flow | - | 1,592 | 460.64 | 1,294 | 1,159 | 405.01 | Upgrade
|
Unlevered Free Cash Flow | - | 1,721 | 546.57 | 1,352 | 1,231 | 496.57 | Upgrade
|
Change in Net Working Capital | -529.04 | -29.22 | 508.39 | -192.98 | -88.41 | 294.25 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.